Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Oxytocin for Chronic Pelvic Pain
NCT02888574Phase 3Completed
- Sponsor
- University of Calgary
- Start
- Nov 2016
- Primary completion
- Dec 2018
- Countries
- 1
01
Overview
A Phase 3 trial of oxytocin nasal spray in chronic pelvic pain (CPP), sponsored by University of Calgary. Started Nov 2016; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
chronic pelvic pain (CPP)
Beyond the preview
Go deeper on NCT02888574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02888574.